98%
921
2 minutes
20
Understanding protein binding to biosensing surfaces is paramount to the design and performance of biosensing devices in fields such as point-of-care testing and bioanalytics. Here, we systematically demonstrated the use of electrical impedance spectroscopy (EIS) and equivalent circuit modeling for real-time tracking of chemisorption of IgG antibody to large-area circular gold electrodes (1.3 mm) functionalized with a self-assembled monolayer (SAM). Using 1 μg/mL IgG and 5 mM of [Fe(CN)], the measured low-frequency impedance proved sensitive to both equilibrium and kinetics of antibody binding, with a slope of ∼74 kΩ/h for the first 2 h and taking approximately 4 h to reach equilibrium in a standard 6 mm-diameter well. Changes in impedance were found to be proportional to the reciprocal of the change in capacitance up to half-to-full IgG monolayer bound to the SAM. Further experiments with a flat microchannel confirmed that the low-frequency impedance and equivalent charge-transfer resistance () depend not only on antibody diffusion but also on the surface-to-volume ratio, which can represent a major challenge previously unreported for the miniaturization of EIS in microfluidic devices. This challenge arises as it requires a higher concentration of [Fe(CN)], of 50 mM or above, which was found to interfere with during chemisorption at low IgG concentrations. Chemisorption of IgG to SAM was confirmed with fluorescence microscopy and FTIR. This study marks, to the best of our knowledge, the first experimental demonstration of EIS as a real-time technique for quantitation of Langmuir isotherms during chemisorption of antibodies to SAM, with the potential to improve the design of EIS-based biosensors, especially those integrated into microfluidic devices.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224300 | PMC |
http://dx.doi.org/10.1021/acs.langmuir.5c01062 | DOI Listing |
Talanta
August 2025
Center of Excellence for Trace Analysis and Biosensor, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand; Division of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand; Center of Excellence Innovation in Chemistr
A novel label-free electrochemical immunosensor was constructed to quantify prostate-specific antigen (PSA) in human serum. A poly(3,4-ethylenedioxythiophene) and Prussian blue nanocomposite (PEDOT@PB) was used to a screen-printed carbon electrode (SPCE) modification to construct the platform followed by a nanocomposite of reduced graphene oxide and copper metal-organic framework (rGO@Cu(BDC-NH) MOF), that was then decorated with porous platinum nanoparticles (PPtNPs). In this system, PEDOT@PB served as a redox probe.
View Article and Find Full Text PDFLangmuir
July 2025
Department of Chemical Engineering, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
Understanding protein binding to biosensing surfaces is paramount to the design and performance of biosensing devices in fields such as point-of-care testing and bioanalytics. Here, we systematically demonstrated the use of electrical impedance spectroscopy (EIS) and equivalent circuit modeling for real-time tracking of chemisorption of IgG antibody to large-area circular gold electrodes (1.3 mm) functionalized with a self-assembled monolayer (SAM).
View Article and Find Full Text PDFChem Biol Interact
November 2024
Grade 2019, Clinical Medicine, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan, 453003, PR China.
The interaction mechanism of spherical gold nanoparticles (AuNPs) and rod-shaped gold nanoparticles (AuNRs) with γ-globulin and hemoglobin was comprehensively and comparatively analyzed. γ-Globulin and hemoglobin have high affinity with AuNPs, and with two different types of binding sites on AuNRs surface. Except hemoglobin interaction with the first binding site of AuNRs, the interaction between γ-globulin/hemoglobin and AuNPs/AuNRs is the spontaneous, endothermic and entropy-driven process, and hydrophobic interaction plays a dominant role.
View Article and Find Full Text PDFBME Front
March 2023
Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Treatments for disease in the central nervous system (CNS) are limited because of difficulties in agent penetration through the blood-brain barrier, achieving optimal dosing, and mitigating off-target effects. The prospect of precision medicine in CNS treatment suggests an opportunity for therapeutic nanotechnology, which offers tunability and adaptability to address specific diseases as well as targetability when combined with antibodies (Abs). Here, we review the strategies to attach Abs to nanoparticles (NPs), including conventional approaches of chemisorption and physisorption as well as attempts to combine irreversible Ab immobilization with controlled orientation.
View Article and Find Full Text PDFNanoscale Adv
September 2023
Department of Molecular and Translational Medicine, University of Brescia Viale Europa 11 25123 Brescia Italy
To be profitably exploited in medicine, nanosized systems must be endowed with biocompatibility, targeting capability, the ability to evade the immune system, and resistance to clearance. Currently, biogenic nanoparticles, such as extracellular vesicles (EVs), are intensively investigated as the platform that naturally recapitulates these highly needed characteristics. EV native targeting properties and pharmacokinetics can be further augmented by decorating the EV surface with specific target ligands as antibodies.
View Article and Find Full Text PDF